ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.

Quote:

Search for Ticker

Free Membership

Search:

PETS: Petmeds Express Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

PETMEDS EXPRESS INC (NASD)
PETS	16.25	-0.04	(-0.25%)	Vol. 171,791	16:00 ET

Petmed Express is America's largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.

General Information

PETMED EXPRESS

1441 S.W. 29th Avenue Pompano Beach, FL 33069 Phone: 954 979-5995 Fax: 954 971-0544 Web: www.1800petmeds.com Email: customerservice@1800petmeds.com

Industry	ELECTRONIC COMMERCE
Sector:	Retail/Wholesale

Fiscal Year End	March
Last Reported Quarter	09/30/09
Next EPS Date	01/19/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	16.29
52 Week High	20.28
52 Week Low	13.14
Beta	0.63
20 Day Moving Average	395,822.06
Target Price Consensus	19.75

% Price Change
4 Week	0.68
12 Week	-10.27
YTD	-7.83

% Price Change Relative to S&P 500
4 Week	-0.41
12 Week	-15.40
YTD	-23.72

Share Information
Shares Outstanding (millions)	22.83
Market Capitalization (millions)	370.97
Short Ratio	16.50
Last Split Date	N/A

Dividend Information
Dividend Yield	2.46%
Annual Dividend	$0.40
Payout Ratio	0.36
Change in Payout Ratio	0.35
Last Dividend Payout / Amount	11/10/2009 / $0.10

EPS Information
Current Quarter EPS Consensus Estimate	0.23
Current Year EPS Consensus Estimate	1.13
Estimated Long-Term EPS Growth Rate	14.80
Next EPS Report Date	01/19/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.43
30 Days Ago	2.43
60 Days Ago	2.25
90 Days Ago	2.25

Fundamental Ratios

P/E
Current FY Estimate:	14.32
Trailing 12 Months:	14.77
PEG Ratio	0.97

EPS Growth
vs. Previous Year	12.00%
vs. Previous Quarter	-22.22%

Sales Growth
vs. Previous Year	4.83%
vs. Previous Quarter:	-19.08%

Price Ratios
Price/Book	4.20
Price/Cash Flow	15.94
Price / Sales	1.61

ROE
09/30/09	30.37
06/30/09	30.68
03/31/09	29.85

ROA
09/30/09	26.81
06/30/09	26.86
03/31/09	26.22

Current Ratio
09/30/09	10.19
06/30/09	4.80
03/31/09	8.82

Quick Ratio
09/30/09	8.13
06/30/09	3.84
03/31/09	4.99

Operating Margin
09/30/09	10.76
06/30/09	10.70
03/31/09	10.47

Net Margin
09/30/09	16.89
06/30/09	16.69
03/31/09	16.25

Pre-Tax Margin
09/30/09	16.89
06/30/09	16.69
03/31/09	16.25

Book Value
09/30/09	3.87
06/30/09	3.69
03/31/09	3.21

Inventory Turnover
09/30/09	7.21
06/30/09	7.23
03/31/09	6.25

Debt-to-Equity
09/30/09	-
06/30/09	0.00
03/31/09	0.00

Debt to Capital
09/30/09	-
06/30/09	0.00
03/31/09	0.00


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research